Key moments in Genzyme's history
AP File Photo/2003
2003 - Fabrazyme gets FDA approval
Fabrazyme, a enzyme replacement drug for Fabry disease, another rare disorder, is approved by the FDA.
Pictured: Dr. Mark Goldberg, senior vice president of clinical research at Genzyme, described the testing of the drug to an FDA advisory committee.